Chemotherapy News and Research

Latest Chemotherapy News and Research

ICNC 2017 to unveil future applications of nuclear cardiology and cardiac CT imaging

Future applications of nuclear cardiology and cardiac computed tomography (CT) imaging are set to be revealed at the International Conference on Nuclear Cardiology and Cardiac CT 2017.

10 Apr 2017

UC Davis professor awarded Mellon Foundation Fellowship to study environmental hazards

Liza Grandia, associate professor of Native American studies at the University of California, Davis, has received a $270,000 Mellon Foundation New Directions Fellowship.

7 Apr 2017

Cancer uses immature immune cells as support system for successful metastasis, study shows

More typically, these immature immune cells might help us fight cancer, but scientists have now shown cancer can commandeer the cells to help it spread.

6 Apr 2017

Protocol violations in reduced radiotherapy lead to worse outcomes in children with brain tumors

A team of investigators has determined that young children participating in a clinical trial to assess the effectiveness of reduced radiotherapy did worse when there were deviations from the treatment protocol.

6 Apr 2017

Short-term fasting during chemotherapy may counteract side effects of common cancer drugs

A short-term fast appears to counteract increases in blood sugar caused by common cancer drugs and protect healthy cells in mice from becoming too vulnerable to chemotherapy, according to new research from the University of Southern California.

4 Apr 2017

OSU scientists find way to fight solid tumors using new cancer-drug delivery system

A new cancer-drug delivery system shows the ability to exploit the oxygen-poor areas of solid tumors that make the growths resistant to standard chemotherapy and radiation treatment.

4 Apr 2017

New microfluidic technique may provide patients with less painful test for multiple myeloma

Multiple myeloma is a cancer of the plasma cells, which are white blood cells produced in bone marrow that churn out antibodies to help fight infection. When plasma cells become cancerous, they produce abnormal proteins, and the cells can build up in bone marrow, ultimately seeping into the bloodstream.

4 Apr 2017

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

A new imaging test may provide the ability to identify ovarian cancer patients who are candidates for an emerging treatment that targets a key enzyme cancer cells need to survive.

3 Apr 2017

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Amgen and UCB today announced results from the fourth year of a Phase 2 study showing the efficacy and safety of a second course of treatment with EVENITY™* (romosozumab), an investigational agent for postmenopausal women with osteoporosis.

3 Apr 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Novel molecules called selective androgen receptor degraders (SARDs) may offer the next generation of treatment options for advanced prostate cancer, a new industry-sponsored study reports. The results of this research will be presented Saturday, April 1, at ENDO 2017, the 99th annual meeting of the Endocrine Society, in Orlando, Fla.

2 Apr 2017

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Novocure announced today results from the second cohort of its phase 2 pilot PANOVA trial studying Tumor Treating Fields (TTFields) in combination with nab-paclitaxel and gemcitabine for the treatment of advanced pancreatic cancer.

31 Mar 2017

Novel Research Grants bring new insight to complexities of lupus

The Lupus Research Alliance announced today the Novel Research Grant Class of 2017. The Lupus Research Alliance Novel Research Grants, the proven platform for innovation, make discovery and scientific progress possible.

30 Mar 2017

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Chemists at the University of Alabama at Birmingham have designed triple-threat cancer-fighting polymer capsules that bring the promise of guided drug delivery closer to preclinical testing.

30 Mar 2017

Combining anticancer drug with antirheumatic produces improved effects against tumors

Scientists at EPFL and NTU have discovered that combining an anticancer drug with an antirheumatic produces improved effects against tumors. The discovery opens a new path for drug-drug synergy.

30 Mar 2017

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

All causes of the most common form of liver cancer, hepatocellular carcinoma, are not yet known, but the risk of getting it is increased by hepatitis B or C, cirrhosis, obesity, diabetes, a buildup of iron in the liver, or a family of toxins called aflatoxins produced by fungi on some types of food.

29 Mar 2017

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

City of Hope, a world-renowned independent research and cancer and diabetes treatment center, will highlight a variety of basic research and population studies at the annual meeting of the American Association for Cancer Research at the Walter E. Washington Convention Center in Washington, D.C., April 1 to 5.

28 Mar 2017

Scientists show p300 protein may stop MDS from developing into leukemia

Scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have shown that p300, a protein that increases gene expression by attaching acetyl molecules to DNA, may stop myelodysplastic syndrome (MDS) from developing into acute myeloid leukemia (AML). The study was published in the journal Leukemia.

27 Mar 2017

Study shows how epigenetic randomness helps cancer cells proliferate

In a research effort that merged genetics, physics and information theory, a team at the schools of medicine and engineering at The Johns Hopkins University has added significantly to evidence that large regions of the human genome have built-in variability in reversible epigenetic modifications made to their DNA.

27 Mar 2017

FDA approves new maintenance therapy for recurrent cancers

The U.S. Food and Drug Administration today approved Zejula (niraparib) for the maintenance treatment (intended to delay cancer growth) of adult patients with recurrent epithelial ovarian, fallopian tube or primary peritoneal cancer, whose tumors have completely or partially shrunk (complete or partial response, respectively) in response to platinum-based chemotherapy.

27 Mar 2017

New study discloses role of specific proteins in killing fast-duplicating cancer cells

Many cancer patients struggle with the adverse effects of chemotherapy, still the most prescribed cancer treatment. For patients with pancreatic cancer and other aggressive cancers, the forecast is more grim: there is no known effective therapy.

27 Mar 2017

Chemotherapy News and Research

Latest Chemotherapy News and Research

ICNC 2017 to unveil future applications of nuclear cardiology and cardiac CT imaging

UC Davis professor awarded Mellon Foundation Fellowship to study environmental hazards

Cancer uses immature immune cells as support system for successful metastasis, study shows

Protocol violations in reduced radiotherapy lead to worse outcomes in children with brain tumors

Short-term fasting during chemotherapy may counteract side effects of common cancer drugs

OSU scientists find way to fight solid tumors using new cancer-drug delivery system

New microfluidic technique may provide patients with less painful test for multiple myeloma

New imaging test can show key enzyme in ovarian cancer to help guide treatment choices

Amgen, UCB present romosozumab Phase 2 results at ENDO 2017

Novel highly potent SARDs may offer treatment option for advanced prostate cancer, study reports

Combination of TTFields with standard therapies may improve survival in pancreatic cancer patients

Novel Research Grants bring new insight to complexities of lupus

UAB chemists design microcapsules for guided drug delivery system to target solid tumors

Combining anticancer drug with antirheumatic produces improved effects against tumors

Researchers aim to examine therapeutic effect of iPS-ML producing interferon-β on liver cancer

City of Hope researchers to highlight basic cancer research and population studies at AACR meeting

Scientists show p300 protein may stop MDS from developing into leukemia

Study shows how epigenetic randomness helps cancer cells proliferate

FDA approves new maintenance therapy for recurrent cancers

New study discloses role of specific proteins in killing fast-duplicating cancer cells

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Digital pathology and the PathoVerse: A conversation with Dr. Singh

Newsletters you may be interested in